Harmony Biosciences Holdings, Inc.
HRMYBiotechnology
$38.59+0.23%As of Oct 29vs prior close
- Market cap
- $2.2B
- P/E (TTM)
- 12.3×
- P/E (FY1)
- 7.4×
- From 52W high
- −9.96%
- EPS (LTM)
- $3.08
- Revenue (LTM)
- $959.9M
- Net margin
- 18.88%
- Dividend yield
- 0.00%
Nomior Score
85
Vanguard CompounderSpeculativeTop 1% of the scored universe
Growth71
Quality72
Value80
Momentum76
Resilience56
Growth
+129.17%revenue a year over 6 fiscal years
YE19 $6MLTM $959.9M
Connections
Revenue to profitQ2 YE26
29% of revenue became net profit, up 9 pts on a year.
Who owns it
2funds